Promoting Use of Effective Early Intervention Programs

描述（由申请人提供）：现在有强大的科学支持，广泛实施经证实的，有效的早期干预计划，为幼儿，或有风险，发育障碍。然而，在实践中，往往执行缺乏证明有效性的方案，破坏了早期干预的影响。目前项目的长期目标是增加0-5岁发育残疾儿童或有可能患有发育残疾的儿童获得有效干预服务的可能性。为此，拟议的第二阶段工作的具体目标将是充分开发和准备商业传播的三个产品，其原型已经存在于第一阶段完成的研发和以前成功的社会计量学产品中。核心产品是早期干预计划档案，以减少发育障碍（EIPARDD），其中将包括完整的复制套件的所有必要的材料（例如，手册、工作簿），以实施和评估医疗支持的干预措施。EIPARDD中包含的干预措施是通过全面的科学文献检索和I期独立专家小组的广泛评价确定的。在第一阶段，获得了12个医疗支持的干预计划，并为一个EIPARDD计划构建了一个原型工具包，并得到了消费者的好评。第二阶段的具体目标是使EIPARDD中每个项目的所有材料在资助期结束前准备好进行商业发行。另外两种产品通过（1）促进为特定需求选择适当的外科支持干预计划来加强EIPARDD的使用（包括那些没有作为复制工具包提供的），通过在线早期干预计划选择资源;和（2）通过一套早期干预方案实施和评估指南，提供普遍和方案，在线和USB闪存驱动器格式的定制实施和评估信息。第二阶段的具体目标是在赠款期结束前使这两种辅助产品准备好进行商业分销。技术可用性测试和消费者反馈将在整个过程中广泛使用，以确保所有最终产品满足早期干预专业人员的需求。此外，还将进行一项混合方法研究，以调查在新地点实施有效的早期干预方案的保真度。将向地方、州和区域各级的早期干预决策者推销复制包。这些产品的商业市场很大，有102 000多名专业人员根据《联邦残疾人教育法》第B和C部分从事早期干预工作，为近100万名0-5岁儿童提供服务。公共卫生相关性：EIPARDD及其相关产品将通过两种关键方式促进公共卫生。它将：（1）通过为EI决策者提供一系列有效的EI计划，为更多有发育迟缓或有发育迟缓风险的幼儿及其家庭提供有效的早期干预服务，以便他们在提供EI服务时轻松且经济地选择、实施、调整和评估他们的努力，以及（2）通过为幼儿教师和培训师提供可访问的交互式研究，为当前和有抱负的EI专家提供针对发育迟缓或有发育迟缓风险的儿童的有效EI计划-基于信息，用于职前准备、工作人员概况介绍、工作人员培训。更广泛的使用，适应和评估有效的EI计划，为儿童或有风险的发展迟缓，更高技能的EI专业人员，应该是结果。

DESCRIPTION (provided by applicant): There is now strong scientific support for the widespread implementation of proven, effective early intervention programs for young children with, or at risk for, developmental disability. However, in practice, programs that lack demonstrated effectiveness are often implemented, undermining the impact of early intervention. The long-term goal of the current project is to increase the likelihood that children ages 0-5 years with or at risk for developmental disability receive effective intervention services. To this end, the specific aims of the proposed Phase II work will be to fully develop and make ready for commercial dissemination three products for which prototypes already exist from R&D completed in Phase I and from prior successful Sociometrics products. The central product is the Early Intervention Program Archive to Reduce Developmental Disability (EIPARDD), which will consist of complete replication kits of all necessary materials (e.g., manuals, workbooks) to implement and evaluate an empirically-supported intervention. Interventions included in EIPARDD were identified through a comprehensive scientific literature search and extensive evaluation by an independent Expert Panel in Phase I. Access to 12 empirically-supported intervention programs was secured in Phase I, and a prototype kit for one EIPARDD program was constructed and favorably evaluated by consumers. The specific aim for Phase II is to make all materials for each program in EIPARDD ready for commercial distribution by the end of the grant period. The other two products enhance the use of EIPARDD by (1) facilitating the selection of the appropriate empirically-supported intervention program for a given need (including those not available as replication kits), through an online Early Intervention Program Selection Resource; and (2) promoting program fidelity and evaluation through a set of Early Intervention Program Implementation and Evaluation Tutorials that offer generalized and program- tailored implementation and evaluation information in online and USB flash drive formats. Specific Phase II aims are to make these two ancillary products ready for commercial distribution by the end of the grant period. Technical usability testing and consumer feedback will be used extensively throughout the process to ensure that all final products meet the needs of early intervention professionals. In addition, a mixed-method research study will be conducted to investigate the fidelity of implementing effective early intervention programs in new sites. The replication kits will be marketed to early intervention decision-makers at local, state and regional levels. The commercial market for these products is substantial with over 102,000 professionals working in early intervention under the federal Individuals with Disabilities Education Act (IDEA) Parts B and C, serving nearly one million children ages 0-5 years. PUBLIC HEALTH RELEVANCE: The EIPARDD and its associated products will promote public health in two key ways. It will: (1) offer more young children with or at risk of developmental delay and their families efficacious early intervention services, by providing EI decision-makers with an array of efficacious EI programs from which to easily and affordably select, implement, adapt, and evaluate their efforts as they deliver EI services, and (2) prepare current and aspiring EI specialists about effective EI programs for children with or at risk of developmental delays by offering early childhood faculty and trainers accessible and interactive research-based information for use in pre-service preparation, staff orientation, staff training. More widespread use, adaptation, and evaluation of efficacious EI programs for children with or at risk for developmental delay, and more highly skilled EI professionals, should be the result.